GILEAD SCIENCES, INC. — Director's Dealing 2018

Dec 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-11-29

Reporting Person: MARTIN JOHN C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-29	Common Stock	G	140000	—	Disposed	2877762	Direct
2018-12-03	Common Stock	M	50000	$23.60	Acquired	2927762	Direct
2018-12-03	Common Stock	S	35842	$70.9048	Disposed	2891920	Direct
2018-12-03	Common Stock	S	13958	$71.9498	Disposed	2877962	Direct
2018-12-03	Common Stock	S	200	$72.665	Disposed	2877762	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-03	Non-qualified Stock Option (Right to Buy)	$23.60	M	50000	Disposed	2019-01-21	Common Stock (50000)	Direct

Footnotes

F1: Shares gifted to charitable trust

F2: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F3: The shares subject to the option have a five year vesting schedule. 20% vest on the first anniversary of the date of the grant. The balance will vest 5% quarterly thereafter until fully vested.

F4: Sale prices reported for the transactions reported here range from $70.55 to $71.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: Sale prices reported for the transactions reported here range from $71.56 to $72.50. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F6: Sale prices reported for the transactions reported here range from $72.59 to $72.74. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.